Literature DB >> 12231448

Effect of chronic thyroxine treatment on catalepsy in rats.

Alexander V Kulikov1, Natalia N Barykina, Maria A Tikhonova, Vera F Chuguy, Victor G Kolpakov, Nina K Popova.   

Abstract

The effect of chronic thyroid hormone (thyroxine, T4) administration on the duration of cataleptic freezing was studied in males of random-bred Wistar and genetic cataleptic (GC) rat strains. It was found that thyroidectomy brought about a sharp increase in immobility time in Wistar rats. Replacement with 0.015 mg/kg per day of T4 for 30 days from the day after thyroidectomy prevented the development of predisposition to catalepsy, whereas the same dose of T4 failed to attenuate the predisposition to catalepsy in the case of a month delay between the thyroidectomy and the beginning of treatment. A chronic administration of T4 at a dose of 0.1 mg/kg per day clearly decreased the genetically determined high expression of cataleptic reaction in GC rats. The results are evidence of the involvement of T4 in the regulation of cataleptic freezing and suggest that predisposition to catalepsy may be caused or enhanced by a deficit of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12231448     DOI: 10.1016/s0304-3940(02)00777-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Effects of experimental increases and decreases in thyroxine levels on the extent of cataleptic freezing reactions in rats.

Authors:  A V Kulikov; M A Tikhonova; E I Lebedeva; V F Chugui; N K Popova
Journal:  Neurosci Behav Physiol       Date:  2005-09

2.  Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain.

Authors:  Caitlin E McOmish; Alena Lira; James B Hanks; Jay A Gingrich
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

3.  Chronic actions of thyroxine on behavior and serotonin receptors in mouse strains with contrasting predispositions to catalepsy.

Authors:  E A Zubkov; A V Kulikov; V S Naumenko; N K Popova
Journal:  Neurosci Behav Physiol       Date:  2009-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.